# US 2020/0399605 A1 · System and method for extraction and cryopreservation of bone marrow

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0399605 A1
- Document ID: US20200399605A1
- Status: Published application
- Kind: A1
- Application number: 17/013,389
- Filed: 2020-09-04
- Published: 2020-12-24
- Earliest claimed: 2019-04-15
- Assignees: Ossium Health, Inc.
- Applicants: Ossium Health, Inc.
- Inventors: Erik John WOODS; Brian H. JOHNSTONE; Dongsheng GU; Aubrey Marie SHERRY; Kelsey Gwen MUSALL; John R. WOODS; James HARDIN; Alan HOOKS
- Web page: https://patentgrep.com/patent/US20200399605A1

## CPC

- C12N 5/0663: {Bone marrow mesenchymal stem cells (BM-MSC)}
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A61B 17/1611: {the two jaw elements being integral with respective elongate shaft elements}
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- C12M 45/02: {by mechanical forces; Stirring; Trituration; Comminuting (crushing, pulverizing, disintegrating in general B02C)}
- C12M 45/05: {by centrifugation (centrifuges in general B04B)}
- A61B 17/1606: {of forceps type, i.e. having two jaw elements moving relative to each other}
- A61B 2017/00831: {Material properties}
- A61B 2017/00969: {used for transplantation}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.

## Claims

### Claim 1

A method for high-yield recovery of stem cells from cadaver bone or cadaver bone fragments, the method comprising:
(a) obtaining cadaver bone or cadaver bone fragments, optionally, processing the cadaver bone into cadaver bone fragments;
(b) combining the cadaver bone fragments with a grinding medium comprising two or more of a nuclease, human serum albumin (HSA), heparin, an electrolyte medium, and a growth media, thereby obtaining grinding medium-treated cadaver bone fragments;
(c) processing the medium-treated cadaver bone fragments to extract bone marrow cells; and
(d) collecting the extracted bone marrow cells, thereby recovering the stem cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nuclease is sold under the trademark Benzonase® or Denarase®.

### Claim at position 3

-7. (canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the nuclease is a DNase.

### Claim 9 (depends on 1)

The method of claim 1, wherein the electrolyte medium is PLASMA-LYTE A.

### Claim 10 (depends on 1)

The method of claim 1, wherein the electrolyte medium is ISOLYTE.

### Claim 11 (depends on 1)

The method of claim 1, wherein the grinding medium comprises three or more of a nuclease, HSA, heparin, an electrolyte medium, and a growth media.

### Claim 12 (depends on 11)

The method of claim 11, wherein the grinding medium comprises Benzonase®, HSA, heparin, and PLASMA-LYTE A.

### Claim 13 (depends on 1)

The method of claim 1, wherein the growth media is Iscove's Modified Dulbecco's Media (IMDM).

### Claim 14 (depends on 1)

The method of claim 1, wherein the processing in step (c) comprises grinding the cadaver bone fragments to obtain ground cadaver bone.

### Claim 15 (depends on 14)

The method of claim 14, wherein the processing in step (c) further comprises a filtering step thereby producing a filtered product comprising extracted bone marrow cells.

### Claim 16 (depends on 15)

The method of claim 15, wherein the filtering comprises a No. 40 (425 μm) sieve and/or a No. 80 (177 μm) sieve.

### Claim 17 (depends on 16)

The method of claim 16, further comprising combining the filtered product with additional grinding medium having components of step (b), thereby obtaining a diluted bone marrow cell product.

### Claim 18 (depends on 17)

The method of claim 17, further comprising a step of further filtering the diluted bone marrow cell product with one or more filters comprising pore sizes ranging from about 200 μm to about 825 μm and/or selected from filters having pore sizes of 200 μm, 500 μm, or 825 μm.

### Claim 19 (depends on 18)

The method of claim of claim 18, further comprising a step removing fat from an intermediate product.

### Claim 20 (depends on 1)

The method of claim 1, wherein the cadaver bone fragments are present in or divided into 1.5 cm2 pieces in step (a).

### Claim 21 (depends on 1)

The method of claim 1, wherein the cadaver bone or the cadaver bone fragments are derived from a vertebral body, an ileum, or a combination thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein the cadaver bone or cadaver bone fragments are derived from a plurality of cadaver bones from the same donor.

### Claim 23 (depends on 1)

The method of claim 1, wherein the extracted stem cells comprise hematopoietic stem cells.

### Claim 24 (depends on 1)

The method of claim 1, wherein the extracted stem cells comprise a Mesenchymal stem cells (MSCs).

### Claim 25 (depends on 12)

The method of claim 12, wherein the grinding medium comprises PLASMA-LYTE-A and comprising 10 U/mL heparin, 2.5% HSA, and 3 U/mL Benzonase®.
